GA

Ganesan Athinarayana Prabu

Active Director Director DIN 10824987
DIN 10824987 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ganesan Athinarayana Prabu

Data last updated:

Ganesan Athinarayana Prabu is a Director at Alfanex Laboratories Private Limited (since 2024). The company operates in Paper.

DIN 10824987
Primary Designation Director
Industry Paper
First Appointment 29 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alfanex Laboratories Private Limited U21001TN2024PTC174408
Director29 Oct 20242024Active

Board colleagues of Ganesan Athinarayana Prabu

NameDINCompanyDesignation
Iqbal Anifa10824986Alfanex Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alfanex Laboratories Private Limited
Premium access

Shareholding and investment profile for Ganesan Athinarayana Prabu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesan Athinarayana Prabu

Ganesan Athinarayana Prabu currently holds 1 directorship: Alfanex Laboratories Private Limited (Director, since 29 Oct 2024).

Ganesan Athinarayana Prabu was first appointed on 29 Oct 2024 as Director at Alfanex Laboratories Private Limited.

The current boards of Ganesan Athinarayana Prabu's companies include Iqbal Anifa (Alfanex Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available